Does low-dose atropine slow myopia progression? Still yes.
A study published in Acta Ophthalmologica investigated the use of low-dose atropine for myopia control in a European pediatric population.
Tell me about the study.
A total of 102 myopic children ranging in age from 5 to 16 were included in the retrospective study. Fifty-two of these children were treated with 0.01% atropine once in the evening for at least 1 year and the others acted as controls. The authors measured the rate of myopia progression in both treated and untreated patients over 12 months.
What did they find?
Low-dose atropine significantly slowed myopia progression. In the treated group, 79% of patients had less than 0.50 D myopic progression over 1 year.
Any adverse events?
Five patients complained of photophobia, although not severe enough to discontinue treatment. No systemic adverse events were reported.
Where can I learn more about myopia management/research/treatments?
The Brien Holden website has a nice myopia calculator, along with other useful information. I've written previously about the DIMS lens, a spectacle lens (still in clinical trials) made by Hoya to help control myopic progression. Finally, here’s one more useful myopia management website.
WHAT YOUR PATIENT MIGHT ASK YOU
Could I die from a vitrectomy?
SOCIAL MEDIA ROUNDUP
Contact Lens Health Week
August 19-23 is the CDC's annual contact lens health week. Learn more here.
Nate Berkus + Novartis
Are you really into contacts?
You should take a trip to this museum.
Thanks for reading! See you next week!